SCHEMBL4869284

SCHEMBL4869284

COc1ccc(-c2c(-c3cccc(C)n3)nn3ccccc23)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HSD17B10 Q99714 3/20 0.42
TP53 P04637 2/20 0.42
HPGD P15428 2/20 0.42
MAPK1 P28482 2/20 0.42
PKM P14618 1/20 0.42
TSHR P16473 1/20 0.42
MAPK14 Q16539 2/20 0.41
THRB P10828 1/20 0.41
TGFBR1 P36897 5/20 0.41
RECQL P46063 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ACACA Q13085 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4873749 0.85 MAPK14 (0.44) MAPTNPC1RAB9AKDM4EALDH1A1
SCHEMBL4872629 0.85 THRB (0.56) MAPTNPC1RAB9AKDM4EMAPK1
SCHEMBL4862130 0.82 TGFBR1 (0.53) KDM4EMAPK1MAPK14THRBTGFBR1
SCHEMBL4873701 0.82 AKT1 (0.46) MAPK1MAPK14THRBTGFBR1
SCHEMBL4872673 0.81 JAK2 (0.42) MAPK14THRBTGFBR1L3MBTL1
SCHEMBL4872814 0.81 MAPK14 (0.45) MAPK1MAPK14THRBTGFBR1
SCHEMBL4872159 0.80 TGFBR1 (0.55) MAPTALDH1A1HSD17B10HPGDMAPK14
SCHEMBL4865628 0.80 MAPK14 (0.44) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL4868119 0.80 MAPK14 (0.60) MAPK14THRBTGFBR1
SCHEMBL4867464 0.79 MAPK14 (0.46) MAPK1MAPK14THRBTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365066-B2 Pyrazolopyridine derivatives as pharmaceutical agents ELI LILLY AND COMPANY (US) 2008-04-29 US claimed
EP-1543001-B1 PYRAZOLOPYRIDINE DERIVATIVES AS TGF BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF CANCER LILLY CO ELI (US) 2007-08-15 EP disclosed